Trial Profile
Clinical Trials Insight: 700060075
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 08 Oct 2010
Price :
$35
*
At a glance
- Drugs Anti-PECAM-1 monoclonal antibody (Primary)
- Indications Advanced breast cancer; Colon cancer; Malignant melanoma
- Focus Adverse reactions
- 08 Oct 2010 New trial record